* BioLife Solutions Inc BLFS.OQ reported a quarterly
adjusted
loss of 6 cents per share for the quarter ended in June. The
mean expectation of nine analysts for the quarter was for a loss
of 21 cents per share.
* Revenue rose 29.9% to $40.53 million from a year ago;
analysts
expected $39.18 million.
* BioLife Solutions Inc's reported EPS for the quarter was a
loss
of $1.71.
* The mean earnings estimate of analysts had fallen by
about 1.2%
in the last three months.
* In the last 30 days one analyst negatively revised an
earnings
estimate
* BioLife Solutions Inc shares had risen by 53.9% this
quarter and
lost 43.0% so far this year.
* The company reported a quarterly loss of $72.55 million.
* Wall Street's median 12-month price target for BioLife
Solutions
Inc is $33.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data August 9
at 10:23 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2022 -0.21 -0.06 Beat
Mar. 31 2022 -0.25 -0.17 Beat
Dec. 31 2021 -0.17 -0.37 Missed
Sep. 30 2021 -0.09 0.00 Beat